[SLRX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
23-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 28.35%
YoY- 6.27%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 1,378 1,243 1,133 1,039 875 165 105 453.77%
PBT -1,717 -1,784 -2,084 -1,882 -2,630 -1,385 -2,230 -15.95%
Tax -42 62 -286 1 -2 0 0 -
NP -1,717 -1,784 -2,084 -1,883 -2,628 -1,385 -2,230 -15.95%
Tax Rate - - - - - - - -
Total Cost 3,095 3,028 3,217 2,922 3,503 1,549 2,335 20.60%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -124.55 -143.51 -183.95 -181.27 -300.33 -840.76 -2,124.68 -84.83%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -2.39 -3.20 -5.46 -14.40 -18.22 -11.48 -77.16 -90.07%
EPS Diluted -2.39 -3.20 -5.46 -14.40 -18.22 -11.48 -77.16 -90.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.